Skip to main content
Top
Published in: Journal of Translational Medicine 1/2014

Open Access 01-12-2014 | Research

Mapping knowledge translation and innovation processes in Cancer Drug Development: the case of liposomal doxorubicin

Authors: David Fajardo-Ortiz, Luis Duran, Laura Moreno, Hector Ochoa, Victor M Castaño

Published in: Journal of Translational Medicine | Issue 1/2014

Login to get access

Abstract

We explored how the knowledge translation and innovation processes are structured when theyresult in innovations, as in the case of liposomal doxorubicin research. In order to map the processes, a literature network analysis was made through Cytoscape and semantic analysis was performed by GOPubmed which is based in the controlled vocabularies MeSH (Medical Subject Headings) and GO (Gene Ontology). We found clusters related to different stages of the technological development (invention, innovation and imitation) and the knowledge translation process (preclinical, translational and clinical research), and we were able to map the historic emergence of Doxil as a paradigmatic nanodrug. This research could be a powerful methodological tool for decision-making and innovation management in drug delivery research.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hurd PD: Scientific literacy: New minds for a changing world. Sci Ed. 1998, 82: 407-416. 10.1002/(SICI)1098-237X(199806)82:3<407::AID-SCE6>3.0.CO;2-G.CrossRef Hurd PD: Scientific literacy: New minds for a changing world. Sci Ed. 1998, 82: 407-416. 10.1002/(SICI)1098-237X(199806)82:3<407::AID-SCE6>3.0.CO;2-G.CrossRef
2.
go back to reference Russell B: The impact of science on society. 1985, Psychology Press, Nueva york Russell B: The impact of science on society. 1985, Psychology Press, Nueva york
3.
go back to reference Drolet BC, Lorenzi NM: Translational research: understanding the continuum from bench to bedside. Transl Res. 2011, 157: 1-5. 10.1016/j.trsl.2010.10.002.CrossRefPubMed Drolet BC, Lorenzi NM: Translational research: understanding the continuum from bench to bedside. Transl Res. 2011, 157: 1-5. 10.1016/j.trsl.2010.10.002.CrossRefPubMed
4.
go back to reference Schumpeter JA: Business cycles. 1939, McGraw-Hill, New York Schumpeter JA: Business cycles. 1939, McGraw-Hill, New York
5.
go back to reference Lenfant C: Shattuck lecture–clinical research to clinical practice–lost in translation?. N Engl J Med. 2003, 349: 868-874. 10.1056/NEJMsa035507.CrossRefPubMed Lenfant C: Shattuck lecture–clinical research to clinical practice–lost in translation?. N Engl J Med. 2003, 349: 868-874. 10.1056/NEJMsa035507.CrossRefPubMed
6.
go back to reference Woolf SH: The meaning of translational research and why it matters. JAMA. 2008, 299: 211-213.PubMed Woolf SH: The meaning of translational research and why it matters. JAMA. 2008, 299: 211-213.PubMed
8.
go back to reference Graham ID, Logan J, Harrison MB, Straus SE, Tetroe J, Caswell W, Robinson N: Lost in knowledge translation: time for a map?. J Contin Educ Health Prof. 2006, 26: 13-24. 10.1002/chp.47.CrossRefPubMed Graham ID, Logan J, Harrison MB, Straus SE, Tetroe J, Caswell W, Robinson N: Lost in knowledge translation: time for a map?. J Contin Educ Health Prof. 2006, 26: 13-24. 10.1002/chp.47.CrossRefPubMed
9.
go back to reference Francis J, Perlin JB: Improving performance through knowledge translation in the Veterans Health Administration. J Contin Educ Health Prof. 2006, 26: 63-71. 10.1002/chp.52.CrossRefPubMed Francis J, Perlin JB: Improving performance through knowledge translation in the Veterans Health Administration. J Contin Educ Health Prof. 2006, 26: 63-71. 10.1002/chp.52.CrossRefPubMed
10.
11.
go back to reference Kon AA: The Clinical and Translational Science Award (CTSA) Consortium and the translational research model. Am J Bioeth. 2008, 8: 58-60. 10.1080/15265160802109389.PubMedCentralCrossRefPubMed Kon AA: The Clinical and Translational Science Award (CTSA) Consortium and the translational research model. Am J Bioeth. 2008, 8: 58-60. 10.1080/15265160802109389.PubMedCentralCrossRefPubMed
12.
go back to reference Etheridge ML, Campbell SA, Erdman AG, Haynes CL, Wolf SM, McCullough J: The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomedicine. 2013, 9: 1-14. 10.1016/j.nano.2012.05.013.PubMedCentralCrossRefPubMed Etheridge ML, Campbell SA, Erdman AG, Haynes CL, Wolf SM, McCullough J: The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomedicine. 2013, 9: 1-14. 10.1016/j.nano.2012.05.013.PubMedCentralCrossRefPubMed
13.
go back to reference Torchilin VP: Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005, 4: 145-160. 10.1038/nrd1632.CrossRefPubMed Torchilin VP: Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005, 4: 145-160. 10.1038/nrd1632.CrossRefPubMed
14.
go back to reference Barenholz Y: Doxil®—The first fda-approved nano-drug: Lessons learned. J Control Release. 2012, 160: 117-134. 10.1016/j.jconrel.2012.03.020.CrossRefPubMed Barenholz Y: Doxil®—The first fda-approved nano-drug: Lessons learned. J Control Release. 2012, 160: 117-134. 10.1016/j.jconrel.2012.03.020.CrossRefPubMed
15.
go back to reference Nijhara R, Balakrishnan K: Bringing nanomedicines to market: regulatory challenges, opportunities, and uncertainties. Nanomedicine. 2006, 2 (2): 127-136. 10.1016/j.nano.2006.04.005.CrossRefPubMed Nijhara R, Balakrishnan K: Bringing nanomedicines to market: regulatory challenges, opportunities, and uncertainties. Nanomedicine. 2006, 2 (2): 127-136. 10.1016/j.nano.2006.04.005.CrossRefPubMed
16.
go back to reference Fajardo-ortiz D, Ochoa H, Garcia L, Castaño V: [Translation of knowledge on cervical cancer: is there a gap between research on causes and research on patient care?] [Article in Spanish]. Cad Saude Publica. 2014, 30: 415-426.PubMed Fajardo-ortiz D, Ochoa H, Garcia L, Castaño V: [Translation of knowledge on cervical cancer: is there a gap between research on causes and research on patient care?] [Article in Spanish]. Cad Saude Publica. 2014, 30: 415-426.PubMed
17.
go back to reference Fajardo-Ortiz D, Duran L, Moreno L, Ochoa H, Castaño VM: Liposomes vs metallic nanostructures: differences in the process of knowledge translation in cancer. Int J Nanomedicine. 2014, 26 (9): 2627-2634. Fajardo-Ortiz D, Duran L, Moreno L, Ochoa H, Castaño VM: Liposomes vs metallic nanostructures: differences in the process of knowledge translation in cancer. Int J Nanomedicine. 2014, 26 (9): 2627-2634.
18.
go back to reference Harris JK, Luke DA, Zuckerman RB, Shelton SC: Forty years of secondhand smoke research the gap between discovery and delivery. Am J Prev Med. 2009, 36: 538-548. 10.1016/j.amepre.2009.01.039.CrossRefPubMed Harris JK, Luke DA, Zuckerman RB, Shelton SC: Forty years of secondhand smoke research the gap between discovery and delivery. Am J Prev Med. 2009, 36: 538-548. 10.1016/j.amepre.2009.01.039.CrossRefPubMed
19.
go back to reference Harris JK: Connecting discovery and delivery: the need for more evidence on effective smoking cessation strategies for people living with HIV/AIDS. Am J Public Health. 2010, 100: 1245-1249. 10.2105/AJPH.2009.172460.PubMedCentralCrossRefPubMed Harris JK: Connecting discovery and delivery: the need for more evidence on effective smoking cessation strategies for people living with HIV/AIDS. Am J Public Health. 2010, 100: 1245-1249. 10.2105/AJPH.2009.172460.PubMedCentralCrossRefPubMed
20.
go back to reference Cambrosio A, Keating P, Mercier S, Lewison G, Mogoutov A: Mapping the emergence and development of translational cancer research. Eur J Cancer. 2006, 42: 3140-3148. 10.1016/j.ejca.2006.07.020.CrossRefPubMed Cambrosio A, Keating P, Mercier S, Lewison G, Mogoutov A: Mapping the emergence and development of translational cancer research. Eur J Cancer. 2006, 42: 3140-3148. 10.1016/j.ejca.2006.07.020.CrossRefPubMed
21.
go back to reference Jones D, Cambrosio A, Mogoutov A: Detection and characterization of translational research in cancer and cardiovascular medicine. J Transl Med. 2011, 9: 57-10.1186/1479-5876-9-57.PubMedCentralCrossRefPubMed Jones D, Cambrosio A, Mogoutov A: Detection and characterization of translational research in cancer and cardiovascular medicine. J Transl Med. 2011, 9: 57-10.1186/1479-5876-9-57.PubMedCentralCrossRefPubMed
23.
go back to reference Lowe HJ, Barnett GO: Understanding and using the medical subject headings (MeSH) vocabulary to perform literature searches. JAMA. 1994, 271: 1103-1108. 10.1001/jama.1994.03510380059038.CrossRefPubMed Lowe HJ, Barnett GO: Understanding and using the medical subject headings (MeSH) vocabulary to perform literature searches. JAMA. 1994, 271: 1103-1108. 10.1001/jama.1994.03510380059038.CrossRefPubMed
24.
go back to reference The Gene Ontology project in 2008. Nucleic Acids Res. 2008, 36: D440-D444. 10.1093/nar/gkm883. The Gene Ontology project in 2008. Nucleic Acids Res. 2008, 36: D440-D444. 10.1093/nar/gkm883.
25.
go back to reference Falagas ME, Pitsouni EI, Malietzis GA, Pappas G: Comparison of PubMed, Scopus, web of science, and Google scholar: strengths and weaknesses. FASEB J. 2008, 22: 338-342. 10.1096/fj.07-9492LSF.CrossRefPubMed Falagas ME, Pitsouni EI, Malietzis GA, Pappas G: Comparison of PubMed, Scopus, web of science, and Google scholar: strengths and weaknesses. FASEB J. 2008, 22: 338-342. 10.1096/fj.07-9492LSF.CrossRefPubMed
26.
go back to reference Newman ME: Power laws, Pareto distributions and Zipf's law. Contemp Phys. 2005, 46: 323-351. 10.1080/00107510500052444.CrossRef Newman ME: Power laws, Pareto distributions and Zipf's law. Contemp Phys. 2005, 46: 323-351. 10.1080/00107510500052444.CrossRef
27.
go back to reference Garfield E: The evolution of the Science Citation Index. Int Microbiol. 2010, 10: 65-69. Garfield E: The evolution of the Science Citation Index. Int Microbiol. 2010, 10: 65-69.
28.
go back to reference Garfield E: From the science of science to Scientometrics visualizing the history of science with HistCite software. J Informetr. 2009, 3: 173-179. 10.1016/j.joi.2009.03.009.CrossRef Garfield E: From the science of science to Scientometrics visualizing the history of science with HistCite software. J Informetr. 2009, 3: 173-179. 10.1016/j.joi.2009.03.009.CrossRef
29.
go back to reference de Nooy W, Mrvar A, Batagelj V (Eds): Exploratory social network analysis with Pajek. 2005, Cambridge University Press, New York de Nooy W, Mrvar A, Batagelj V (Eds): Exploratory social network analysis with Pajek. 2005, Cambridge University Press, New York
30.
go back to reference Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, Workman C, Christmas R, Avila-Campilo I, Creech M, Gross B, Hanspers K, Isserlin R, Kelley R, Killcoyne S, Lotia S, Maere S, Morris J, Ono K, Pavlovic V, Pico AR, Vailaya A, Wang PL, Adler A, Conklin BR, Hood L, Kuiper M, Sander C, Schmulevich I, Schwikowski B, Warner GJ: Integration of biological networks and gene expression data using Cytoscape. Nat Protoc. 2007, 2: 2366-2382. 10.1038/nprot.2007.324.PubMedCentralCrossRefPubMed Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, Workman C, Christmas R, Avila-Campilo I, Creech M, Gross B, Hanspers K, Isserlin R, Kelley R, Killcoyne S, Lotia S, Maere S, Morris J, Ono K, Pavlovic V, Pico AR, Vailaya A, Wang PL, Adler A, Conklin BR, Hood L, Kuiper M, Sander C, Schmulevich I, Schwikowski B, Warner GJ: Integration of biological networks and gene expression data using Cytoscape. Nat Protoc. 2007, 2: 2366-2382. 10.1038/nprot.2007.324.PubMedCentralCrossRefPubMed
31.
go back to reference Spinelli L, Gambette P, Chapple CE, Robisson B, Baudot A, Garreta H, Tichit L, Guénoche A, Brun C: Clust&see: a Cytoscape plugin for the identification, visualization and manipulation of network clusters. Biosystems. 2013, 113: 91-95. 10.1016/j.biosystems.2013.05.010.CrossRefPubMed Spinelli L, Gambette P, Chapple CE, Robisson B, Baudot A, Garreta H, Tichit L, Guénoche A, Brun C: Clust&see: a Cytoscape plugin for the identification, visualization and manipulation of network clusters. Biosystems. 2013, 113: 91-95. 10.1016/j.biosystems.2013.05.010.CrossRefPubMed
32.
go back to reference Newman ME: Fast algorithm for detecting community structure in networks. Phys Rev E. 2004, 69: 066133-10.1103/PhysRevE.69.066133.CrossRef Newman ME: Fast algorithm for detecting community structure in networks. Phys Rev E. 2004, 69: 066133-10.1103/PhysRevE.69.066133.CrossRef
33.
go back to reference Mihalik Á, Csermely P: Heat shock partially dissociates the overlapping modules of the yeast protein-protein interaction network: a systems level model of adaptation. PLoS Comput Biol. 2011, 7: e1002187-10.1371/journal.pcbi.1002187.PubMedCentralCrossRefPubMed Mihalik Á, Csermely P: Heat shock partially dissociates the overlapping modules of the yeast protein-protein interaction network: a systems level model of adaptation. PLoS Comput Biol. 2011, 7: e1002187-10.1371/journal.pcbi.1002187.PubMedCentralCrossRefPubMed
34.
go back to reference Chen C, Cribbin T, Macredie R, Morar S: Visualizing and tracking the growth of competing paradigms: Two case studies. J Am Soc Inform Sci Tech. 2002, 53: 678-689. 10.1002/asi.10075.CrossRef Chen C, Cribbin T, Macredie R, Morar S: Visualizing and tracking the growth of competing paradigms: Two case studies. J Am Soc Inform Sci Tech. 2002, 53: 678-689. 10.1002/asi.10075.CrossRef
35.
go back to reference Lucio-Arias D, Leydesdorff L: Main-path analysis and path-dependent transitions in HistCite™ -based historiograms. J Am Soc Inform Sci Tech. 2008, 59: 1948-1962. 10.1002/asi.20903.CrossRef Lucio-Arias D, Leydesdorff L: Main-path analysis and path-dependent transitions in HistCite™ -based historiograms. J Am Soc Inform Sci Tech. 2008, 59: 1948-1962. 10.1002/asi.20903.CrossRef
36.
go back to reference Seglen PO: Why the impact factor of journals should not be used for evaluating research. Br Med J. 1997, 314: 498-502. 10.1136/bmj.314.7079.497.CrossRef Seglen PO: Why the impact factor of journals should not be used for evaluating research. Br Med J. 1997, 314: 498-502. 10.1136/bmj.314.7079.497.CrossRef
37.
go back to reference Coryn CLS: The use and abuse of citations as indicators of research quality. J Multidiscip Eval. 2007, 3: 115-121. Coryn CLS: The use and abuse of citations as indicators of research quality. J Multidiscip Eval. 2007, 3: 115-121.
38.
go back to reference Shibata N, Kajikawa Y, Takeda Y, Matsushima K: Detecting emerging research fronts based on topological measures in citation networks of scientific publications. Technovation. 2008, 28: 758-775. 10.1016/j.technovation.2008.03.009.CrossRef Shibata N, Kajikawa Y, Takeda Y, Matsushima K: Detecting emerging research fronts based on topological measures in citation networks of scientific publications. Technovation. 2008, 28: 758-775. 10.1016/j.technovation.2008.03.009.CrossRef
39.
go back to reference Rajan A, Sullivan R, Bakker S, van Harten WH: Critical appraisal of translational research models for suitability in performance assessment of cancer centers. Oncologist. 2012, 17: e48-e57. 10.1634/theoncologist.2012-0216.PubMedCentralCrossRefPubMed Rajan A, Sullivan R, Bakker S, van Harten WH: Critical appraisal of translational research models for suitability in performance assessment of cancer centers. Oncologist. 2012, 17: e48-e57. 10.1634/theoncologist.2012-0216.PubMedCentralCrossRefPubMed
Metadata
Title
Mapping knowledge translation and innovation processes in Cancer Drug Development: the case of liposomal doxorubicin
Authors
David Fajardo-Ortiz
Luis Duran
Laura Moreno
Hector Ochoa
Victor M Castaño
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2014
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-014-0227-9

Other articles of this Issue 1/2014

Journal of Translational Medicine 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.